We are live on
!
Find out more
DF
DC Funds Portfolio holdings
AUM
$1.49M
1-Year Est. Return
18.57%
This Fund
S&P 500
This Quarter
Est. Return
-7.34%
1 Year Est. Return
-18.57%
3 Year Est. Return
-38.34%
5 Year Est. Return
-87.14%
10 Year Est. Return
–
AUM
$25.5M
AUM Growth
+$4.42M
(+21%)
Cap. Flow
+$5.84M
Cap. Flow
% of AUM
22.94%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TScan Therapeutics
TCRX
|
+$5.84M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
HGCK
DILIH
CA
AI
SH
CAM
SCM
AMC
DC Funds's Q3 2021 Portfolio in Review
As of Q3 2021, DC Funds held 3 positions worth $25.5M, up 21% from $21.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
DC Funds deployed $5.84M of net new capital in Q3 2021, opening 1 new position. Its largest new stake was TScan Therapeutics: 630,000 shares worth $5.25M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- DC Funds's largest Q3 2021 buy was TScan Therapeutics: 630,000 shares worth $5.25M.
- DC Funds's ten largest holdings make up 100% of its $25.5M portfolio in Q3 2021.
- DC Funds opened 1 new position and closed 0 in Q3 2021.
- DC Funds's portfolio value rose 21% quarter-over-quarter to $25.5M.
Based on DC Funds's 13F filing for Q3 2021, filed 12 Nov 2021.